Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth.

Soman NR, Baldwin SL, Hu G, Marsh JN, Lanza GM, Heuser JE, Arbeit JM, Wickline SA, Schlesinger PH.

J Clin Invest. 2009 Sep;119(9):2830-42. doi: 10.1172/JCI38842. Epub 2009 Aug 10.

2.

Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy.

Pan H, Soman NR, Schlesinger PH, Lanza GM, Wickline SA.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 May-Jun;3(3):318-27. doi: 10.1002/wnan.126. Epub 2011 Jan 10. Review.

PMID:
21225660
3.

The ligand nanoparticle conjugation approach for targeted cancer therapy.

Karra N, Benita S.

Curr Drug Metab. 2012 Jan;13(1):22-41. Review.

PMID:
21892918
4.

Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.

Koning GA, Krijger GC.

Anticancer Agents Med Chem. 2007 Jul;7(4):425-40. Review.

PMID:
17630918
5.

Active targeting strategies for anticancer drug nanocarriers.

Basile L, Pignatello R, Passirani C.

Curr Drug Deliv. 2012 May;9(3):255-68. Review.

PMID:
22452402
6.

Melittin: a lytic peptide with anticancer properties.

Gajski G, Garaj-Vrhovac V.

Environ Toxicol Pharmacol. 2013 Sep;36(2):697-705. doi: 10.1016/j.etap.2013.06.009. Epub 2013 Jun 28. Review.

PMID:
23892471
7.
8.

Designing a better theranostic nanocarrier for cancer applications.

Nguyen T, Tekrony A, Yaehne K, Cramb DT.

Nanomedicine (Lond). 2014 Oct;9(15):2371-86. doi: 10.2217/nnm.14.110. Review.

PMID:
25413855
9.

Environmentally responsive peptides as anticancer drug carriers.

Aluri S, Janib SM, Mackay JA.

Adv Drug Deliv Rev. 2009 Sep 30;61(11):940-52. doi: 10.1016/j.addr.2009.07.002. Epub 2009 Jul 20. Review.

Items per page

Supplemental Content

Write to the Help Desk